Joao Conde is an independent researcher formally at the Massachusetts Institute of Technology, USA, and Queen Mary University, London, UK. His research interests include (i) biofunctionalization of multifunctional metal nanoparticles with DNA/RNA, siRNA, drugs, dendrimers, fluorescent dyes, polymers, proteins/peptides and antibodies for (ii) cancer therapy and (iii) diagnostics; (iv) in vitro and in vivo applications of new nanomaterials and (v) nanoparticles toxicity/biocompatibility studies. He has published 50 articles in peer-reviewed articles and sits on the Editor Board of two journals.

• 1. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine2. Self-Assembled Nanogels: From Particles to Scaffolds and Membranes3. Single and Multiphoton Responsive Nanomaterials for the Investigation of Cancer Microenvironment4. Graphene as 2D Nano-Theranostic Materials for Cancer5. Applications of Plasmonic Nanomaterials for Phototriggered Theranostics6. Bioengineered Ferritin Nanoprobes for Cancer Theranostics7. The Role of Nanoscience in Cancer Diagnosis8. Nanotheranostics and Their Potential in the Management of Metastatic Cancer9. Targeted Nanotheranostics for Selective Drug Delivery in Cancer10. Considerations for the Human Health Implications of Nanotheranostics11. Nanomaterials for Theranostics of Gastric Cancer12. Nanomaterial Based Photo-Triggered Drug Delivery Strategies for Cancer Theranostics13. Bio-Nano Interactions14. Inorganic Nanotheranostic Platforms for Rapid and Reliable Molecular Profiling of Diseases15. Hydrogels as a New Platform to Recapitulate the Tumor Microenvironment16. Lipid-Based Nanosystems for the Delivery of siRNA: Challenges and Trends17. Multiparametric Preclinical Assessment of Theranostics Materials18. RNAi Nanomaterials and Nanovehicles: Inorganic Nanoparticles for RNAi19. Theranostic Magnetic Nanoparticles as Molecular Imaging Agents for siRNA Delivery

Joao Conde is an independent researcher formally at the Massachusetts Institute of Technology, USA, and Queen Mary University, London, UK. His research interests include (i) biofunctionalization of multifunctional metal nanoparticles with DNA/RNA, siRNA, drugs, dendrimers, fluorescent dyes, polymers, proteins/peptides and antibodies for (ii) cancer therapy and (iii) diagnostics; (iv) in vitro and in vivo applications of new nanomaterials and (v) nanoparticles toxicity/biocompatibility studies. He has published 50 articles in peer-reviewed articles and sits on the Editor Board of two journals.

• 1. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine2. Self-Assembled Nanogels: From Particles to Scaffolds and Membranes3. Single and Multiphoton Responsive Nanomaterials for the Investigation of Cancer Microenvironment4. Graphene as 2D Nano-Theranostic Materials for Cancer5. Applications of Plasmonic Nanomaterials for Phototriggered Theranostics6. Bioengineered Ferritin Nanoprobes for Cancer Theranostics7. The Role of Nanoscience in Cancer Diagnosis8. Nanotheranostics and Their Potential in the Management of Metastatic Cancer9. Targeted Nanotheranostics for Selective Drug Delivery in Cancer10. Considerations for the Human Health Implications of Nanotheranostics11. Nanomaterials for Theranostics of Gastric Cancer12. Nanomaterial Based Photo-Triggered Drug Delivery Strategies for Cancer Theranostics13. Bio-Nano Interactions14. Inorganic Nanotheranostic Platforms for Rapid and Reliable Molecular Profiling of Diseases15. Hydrogels as a New Platform to Recapitulate the Tumor Microenvironment16. Lipid-Based Nanosystems for the Delivery of siRNA: Challenges and Trends17. Multiparametric Preclinical Assessment of Theranostics Materials18. RNAi Nanomaterials and Nanovehicles: Inorganic Nanoparticles for RNAi19. Theranostic Magnetic Nanoparticles as Molecular Imaging Agents for siRNA Delivery

Joao Conde is an independent researcher formally at the Massachusetts Institute of Technology, USA, and Queen Mary University, London, UK. His research interests include (i) biofunctionalization of multifunctional metal nanoparticles with DNA/RNA, siRNA, drugs, dendrimers, fluorescent dyes, polymers, proteins/peptides and antibodies for (ii) cancer therapy and (iii) diagnostics; (iv) in vitro and in vivo applications of new nanomaterials and (v) nanoparticles toxicity/biocompatibility studies. He has published 50 articles in peer-reviewed articles and sits on the Editor Board of two journals.

• 1. The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine2. Self-Assembled Nanogels: From Particles to Scaffolds and Membranes3. Single and Multiphoton Responsive Nanomaterials for the Investigation of Cancer Microenvironment4. Graphene as 2D Nano-Theranostic Materials for Cancer5. Applications of Plasmonic Nanomaterials for Phototriggered Theranostics6. Bioengineered Ferritin Nanoprobes for Cancer Theranostics7. The Role of Nanoscience in Cancer Diagnosis8. Nanotheranostics and Their Potential in the Management of Metastatic Cancer9. Targeted Nanotheranostics for Selective Drug Delivery in Cancer10. Considerations for the Human Health Implications of Nanotheranostics11. Nanomaterials for Theranostics of Gastric Cancer12. Nanomaterial Based Photo-Triggered Drug Delivery Strategies for Cancer Theranostics13. Bio-Nano Interactions14. Inorganic Nanotheranostic Platforms for Rapid and Reliable Molecular Profiling of Diseases15. Hydrogels as a New Platform to Recapitulate the Tumor Microenvironment16. Lipid-Based Nanosystems for the Delivery of siRNA: Challenges and Trends17. Multiparametric Preclinical Assessment of Theranostics Materials18. RNAi Nanomaterials and Nanovehicles: Inorganic Nanoparticles for RNAi19. Theranostic Magnetic Nanoparticles as Molecular Imaging Agents for siRNA Delivery